Piers Ingram is the founder of Hummingbird Bioscience. Hummingbird Bioscience has raised $125M in total funding. Latest round: Series C.
Piers Ingram is the co-founder and chief executive officer of Hummingbird Bioscience, a Singapore-based clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets. He was interviewed after the company’s Series C financing.
Full founder directory · Investor directory · Company funding database · Fundraising library